Atlas Trials

Adult Patients With Adverse Risk Acute Myeloblastic Leukemia

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Adult Patients With Adverse Risk Acute Myeloblastic Leukemia

RecordFirmDate
Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM) (NCT05749276)Nantes University Hospital2025-02-06

Track Adult Patients With Adverse Risk Acute Myeloblastic Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.